Please refer the attached intimation.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transchem Limited's board approved unaudited financial results for Q2 and H1 FY26 (ended September 30, 2025). Total income for H1 FY26 stood at ₹331.20 lakhs, down about 30% from ₹477.72 lakhs in H1 FY25. Net profit fell sharply to ₹167.25 lakhs (H1 FY26) from ₹310.67 lakhs (H1 FY25), a decline of roughly 46%; EPS for H1 FY26 was ₹1.37 vs ₹2.54. The Limited Review Report from M/s. Mathur & Co. is unqualified with no observations. Separately, the board gave in-principle approval to acquire 100% (1,55,16,000 shares) of Greshma Shares & Stocks Limited, a stock-broking and depository participant firm with FY25 turnover of ₹11.32 crore, for cash consideration. GSSL will become a wholly owned subsidiary upon completion, marking Transchem's entry into financial services and broking.
Sharp year-on-year decline in both revenue and profits, combined with a large negative operating cash flow (₹4,145.65 lakhs in H1 FY26 vs ₹190.14 lakhs in H1 FY25), is a concern for existing shareholders. However, the proposed diversification into stock broking and capital markets through the GSSL acquisition could open a new growth vertical if executed well.